DK2310043T4 - Faktor VIII samt von Willebrand faktor til behandling af koagulationsdefekt in-duceret af trombocythæmmere - Google Patents
Faktor VIII samt von Willebrand faktor til behandling af koagulationsdefekt in-duceret af trombocythæmmere Download PDFInfo
- Publication number
- DK2310043T4 DK2310043T4 DK09777111.7T DK09777111T DK2310043T4 DK 2310043 T4 DK2310043 T4 DK 2310043T4 DK 09777111 T DK09777111 T DK 09777111T DK 2310043 T4 DK2310043 T4 DK 2310043T4
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- factor
- von willebrand
- platelet inhibitors
- defect induced
- Prior art date
Links
- 108010054218 Factor VIII Proteins 0.000 title 1
- 102000001690 Factor VIII Human genes 0.000 title 1
- 208000015294 blood coagulation disease Diseases 0.000 title 1
- 230000009852 coagulant defect Effects 0.000 title 1
- 229960000301 factor viii Drugs 0.000 title 1
- 239000000106 platelet aggregation inhibitor Substances 0.000 title 1
- 108010047303 von Willebrand Factor Proteins 0.000 title 1
- 102100036537 von Willebrand factor Human genes 0.000 title 1
- 229960001134 von willebrand factor Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008032361A DE102008032361A1 (de) | 2008-07-10 | 2008-07-10 | Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie |
| PCT/EP2009/005027 WO2010003687A1 (en) | 2008-07-10 | 2009-07-10 | Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK2310043T3 DK2310043T3 (da) | 2013-01-07 |
| DK2310043T4 true DK2310043T4 (da) | 2022-06-20 |
Family
ID=41171229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09777111.7T DK2310043T4 (da) | 2008-07-10 | 2009-07-10 | Faktor VIII samt von Willebrand faktor til behandling af koagulationsdefekt in-duceret af trombocythæmmere |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8603979B2 (enExample) |
| EP (1) | EP2310043B2 (enExample) |
| JP (1) | JP5653916B2 (enExample) |
| KR (1) | KR20110043654A (enExample) |
| CN (1) | CN102088999A (enExample) |
| AU (1) | AU2009268289B2 (enExample) |
| CA (1) | CA2730290C (enExample) |
| DE (1) | DE102008032361A1 (enExample) |
| DK (1) | DK2310043T4 (enExample) |
| ES (1) | ES2395855T5 (enExample) |
| PL (1) | PL2310043T5 (enExample) |
| RU (1) | RU2563236C2 (enExample) |
| WO (1) | WO2010003687A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11197916B2 (en) | 2007-12-28 | 2021-12-14 | Takeda Pharmaceutical Company Limited | Lyophilized recombinant VWF formulations |
| JP5784907B2 (ja) | 2007-12-28 | 2015-09-24 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 組換え型ｖｗｆ製剤 |
| PL2300497T3 (pl) * | 2008-06-24 | 2013-02-28 | Octapharma Ag | Sposób oczyszczania czynnika krzepnięcia VIII |
| DE102008032361A1 (de) * | 2008-07-10 | 2010-01-21 | Csl Behring Gmbh | Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie |
| AR074054A1 (es) | 2008-10-21 | 2010-12-22 | Baxter Healthcare Sa | Formulaciones farmaceuticas de factor de von willebrand recombinante liofilizado |
| RS59670B1 (sr) | 2012-01-12 | 2020-01-31 | Bioverativ Therapeutics Inc | Himerni polipeptidi faktora viii i njihove upotrebe |
| WO2013083858A1 (en) | 2012-04-24 | 2013-06-13 | Novo Nordisk A/S | Compounds suitable for treatment of haemophilia |
| EP2662083A1 (en) * | 2012-05-08 | 2013-11-13 | CSL Behring GmbH | Sugar compositions for treating hemophilia a and/or von willebrand disease |
| CN102776260B (zh) * | 2012-07-26 | 2015-04-29 | 上海泰龙生物医药科技有限公司 | 一种高效表达重组人凝血八因子的方法 |
| DK2796145T3 (da) | 2013-04-22 | 2018-01-29 | Csl Ltd | Et kovalent kompleks af von Willebrand-faktor og faktor VIII linket af en disulfidbro |
| CN103263663B (zh) * | 2013-06-08 | 2016-05-04 | 兆科药业（合肥）有限公司 | 一种抗血小板溶栓素在制备治疗vwf缺陷型血管栓塞性疾病的药物中的应用 |
| US10231993B2 (en) | 2013-06-27 | 2019-03-19 | University Of Washington Through Its Center For Commercialization | Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4430205A1 (de) | 1994-08-26 | 1996-02-29 | Behringwerke Ag | Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung |
| US6518482B2 (en) | 1994-09-13 | 2003-02-11 | American National Red Cross | Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor |
| DE4437544A1 (de) * | 1994-10-20 | 1996-04-25 | Behringwerke Ag | Einsatz von vWF-enthaltenden Konzentraten als Kombinationstherapie bei Therapie mit Antithrombotika und Fibrinolytika |
| FR2744918B1 (fr) | 1996-02-19 | 1998-05-07 | Sanofi Sa | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
| FI974321A0 (fi) * | 1997-11-25 | 1997-11-25 | Jenny Ja Antti Wihurin Rahasto | Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa |
| WO2001047547A1 (en) † | 1999-12-24 | 2001-07-05 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy |
| DE102008032361A1 (de) * | 2008-07-10 | 2010-01-21 | Csl Behring Gmbh | Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie |
-
2008
- 2008-07-10 DE DE102008032361A patent/DE102008032361A1/de not_active Withdrawn
-
2009
- 2009-07-10 US US13/003,139 patent/US8603979B2/en active Active
- 2009-07-10 CN CN2009801264767A patent/CN102088999A/zh active Pending
- 2009-07-10 JP JP2011517038A patent/JP5653916B2/ja active Active
- 2009-07-10 WO PCT/EP2009/005027 patent/WO2010003687A1/en not_active Ceased
- 2009-07-10 RU RU2011104705/15A patent/RU2563236C2/ru active
- 2009-07-10 KR KR1020117002934A patent/KR20110043654A/ko not_active Ceased
- 2009-07-10 AU AU2009268289A patent/AU2009268289B2/en active Active
- 2009-07-10 DK DK09777111.7T patent/DK2310043T4/da active
- 2009-07-10 EP EP09777111.7A patent/EP2310043B2/en active Active
- 2009-07-10 PL PL09777111.7T patent/PL2310043T5/pl unknown
- 2009-07-10 ES ES09777111T patent/ES2395855T5/es active Active
- 2009-07-10 CA CA2730290A patent/CA2730290C/en active Active
-
2013
- 2013-11-04 US US14/071,193 patent/US9095564B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010003687A1 (en) | 2010-01-14 |
| US20110112023A1 (en) | 2011-05-12 |
| EP2310043B1 (en) | 2012-09-19 |
| CA2730290C (en) | 2017-02-07 |
| AU2009268289A1 (en) | 2010-01-14 |
| PL2310043T5 (pl) | 2024-02-05 |
| ES2395855T5 (es) | 2022-09-06 |
| JP5653916B2 (ja) | 2015-01-14 |
| CA2730290A1 (en) | 2010-01-14 |
| ES2395855T3 (es) | 2013-02-15 |
| PL2310043T3 (pl) | 2013-02-28 |
| DE102008032361A1 (de) | 2010-01-21 |
| JP2011527301A (ja) | 2011-10-27 |
| RU2563236C2 (ru) | 2015-09-20 |
| US8603979B2 (en) | 2013-12-10 |
| RU2011104705A (ru) | 2012-08-20 |
| US20140128325A1 (en) | 2014-05-08 |
| EP2310043A1 (en) | 2011-04-20 |
| KR20110043654A (ko) | 2011-04-27 |
| EP2310043B2 (en) | 2022-05-18 |
| AU2009268289B2 (en) | 2014-11-06 |
| CN102088999A (zh) | 2011-06-08 |
| US9095564B2 (en) | 2015-08-04 |
| DK2310043T3 (da) | 2013-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2310043T4 (da) | Faktor VIII samt von Willebrand faktor til behandling af koagulationsdefekt in-duceret af trombocythæmmere | |
| EP4091585C0 (en) | DEVICE FOR TREATMENT OF PATHOLOGICAL GASTRO-SOPHAGEAL REFLUX | |
| ATE523949T1 (de) | Verfahren zur regelung von wechselrichtern | |
| EP2114460A4 (en) | METHODS AND COMPOSITIONS FOR THE DISRUPTION OF BIOLOGICAL FILMS | |
| ATE467672T1 (de) | Verfahren zur behandlung von bohrlöchern mit wiederverwertbaren flüssigkeiten | |
| EP1973497A4 (en) | DEVICE FOR RAPID REPAIR OF BODY CONDUITS | |
| DK2245069T3 (da) | Humaniserede antistoffer specifikke for von Willebrand faktor | |
| EP2432599A4 (en) | HARD DISK DRIVE DESTRUCTION SYSTEM | |
| EP3556934C0 (en) | METHODS FOR REGULATING CALCIUM AND/OR SCALE PRECIPITATION | |
| EP2795681A4 (en) | CIRCUITS AND METHODS FOR LIMITING OPEN CIRCUIT VOLTAGE OF PHOTOVOLTAIC CHAINS | |
| DE602007010303D1 (de) | Verwendung von 3- (4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidin--2,6-dion zur behandlung von mantelzelllymphomen | |
| EP2217694A4 (en) | METHODS FOR RAPID MICROFABRICATION USING THERMOPLASTICS AND DEVICES THEREFOR | |
| EP2106410A4 (en) | METHOD FOR SULFONATION OF BLOCKED POLYMERS | |
| AT505105A3 (de) | Verfahren zur beurteilung der fahrbarkeit von fahrzeugen | |
| BRPI0907146A2 (pt) | recipiente plástico de uma peça e método de fazer o mesmo | |
| EP2579936A4 (en) | INTRAGASTRIC DEVICE FOR TREATING OBESITY | |
| DE602007005067D1 (de) | Anlage zur Lagerung von Artikeln und Steuerverfahren dafür | |
| EP2403503A4 (en) | METHODS FOR TREATING OCULAR INFLAMMATORY DISEASES | |
| EP2257516A4 (en) | METHODS FOR PREPARING CYCLODODECATRIENE AND METHODS FOR PREPARING LAUROLACTONE | |
| ATE530575T1 (de) | Demannosylierter rekombinanter faktor viii zur behandlung von patienten mit hämophilie a | |
| EP2278979A4 (en) | PROCESS FOR TREATING PNEUMOCONIOSIS WITH OLIGODEOXYNUCLEOTIDES | |
| DE602007005747D1 (de) | System zur Entfernung von Kalkablagerungen | |
| DE502008001916D1 (de) | Verfahren zur nachträglichen Verstärkung von spritz-gegossenen Transportmitteln | |
| EP2254603A4 (en) | METHODS FOR INHIBITING EYA AND SIX1 PROTEINS | |
| EP2249765A4 (en) | DAPSONE TO TREAT THE ROSACEA |